Search results
J&J consumer brand spinoff Kenvue debuts on NYSE
Yahoo Finance· 1 year agoKenvue (KVUE), the new spinoff of Johnson & Johnson's (JNJ) consumer brand segment, debuted on the New York Stock Exchange Thursday at $25.53 per share.
J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost
Reuters via Yahoo Finance· 11 months agoKenvue, the former consumer health unit of Johnson & Johnson, forecast full-year profit above Wall...
Kenvue Revamps Cyber Tools After Spinoff From J&J
The Wall Street Journal· 2 months agoPRO CYBER NEWS Nearly one year since an initial public offering, consumer-products company Kenvue is hiring more cybersecurity staff and moving away from...
Kenvue's IPO Extravaganza: A Historic $41 Billion Spinoff from Johnson & Johnson
Benzinga via Yahoo Finance· 1 year agoJohnson & Johnson's (NYSE: JNJ) consumer-healthcare business carve-out, Kenvue Inc, priced its...
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO...
Benzinga via Yahoo Finance· 1 year agoJohnson & Johnson (NYSE: JNJ) is reportedly readying an investor roadshow to pitch shares of its...
J&J to exit spinoff Kenvue with latest stake sale
Reuters via Yahoo Finance· 1 month agoBased on Kenvue stock's last close, the offering of 182.3 million shares would be worth about $3.75 billion, according to Reuters calculation. Kenvue's...
Kenvue Is a Timely Stock
GuruFocus.com via Yahoo Finance· 10 months agoKenvue Inc. (NYSE:KVUE), the consumer products division of health care giant Johnson & Johnson (NYSE:JNJ), will fully separate from its parent next week...
Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
Reuters via Yahoo Finance· 1 month agoSince its spinoff from Johnson & Johnson last year, Kenvue has focused on its 15 priority brands and...
Johnson & Johnson-Spinoff Kenvue Earnings Debut: Q2 Beats Consensus, Issues Upbeat Outlook
Benzinga via Yahoo Finance· 11 months agoJohnson & Johnson's former consumer unit, Kenvue Inc (NYSE: KVUE), reported its first quarterly...
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Motley Fool· 1 year agoIn this podcast, Motley Fool producer Ricky Mulvey and senior analyst Asit Sharma discuss: Johnson & Johnson's spinoff of its consumer health company,...
